TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20937922

Group type: EXPERIMENTAL
Intervention: Smoking cessation training (intervention group)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Skin cancer prevention training (control group)
Number of subjects: 170
Study: 19092244

Group type: EXPERIMENTAL
Intervention: Crofelemer 500 mg
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Crofelemer 125 mg
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Crofelemer 250 mg
Number of subjects: 242
Study: 16145414

Group type: COMPARATOR
Intervention: Doxazosin controlled release gastrointestinal therapeutic system formulation (4 mg once daily)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Propiverine hydrochloride (20 mg once daily) plus doxazosin controlled release gastrointestinal therapeutic system formulation
Number of subjects: 211
Study: 11827582

Group type: EXPERIMENTAL
Intervention: Debridement of the left or right ethmoid cavity
Number of subjects: 17

Group type: COMPARATOR
Intervention: No debridement
Number of subjects: 17
Study: 10418762

Group type: EXPERIMENTAL
Intervention: CGP 56697 (4 x 4 tablets over 48 h)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Halofantrine (3 x 2 tablets over 12 h with a second course 1 week later)
Number of subjects: 103
Study: 7736317

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 13
Study: 1828348

Group type: EXPERIMENTAL
Intervention: Potassium supplementation (80 mmol/day KCl for 4 days)
Number of subjects: 0
Study: 7027988

Group type: EXPERIMENTAL
Intervention: Behavior therapy package
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insight-oriented therapy
Number of subjects: 0
Study: 29470317

Group type: EXPERIMENTAL
Intervention: Leukocyte Filter
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 28234437

Group type: EXPERIMENTAL
Intervention: Active drugs (mood stabilizer plus adjunctive antidepressant)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 25975974

Group type: EXPERIMENTAL
Intervention: LipiView® ocular surface interferometer
Number of subjects: 20
Study: 24067460

Group type: EXPERIMENTAL
Intervention: Sulphurous thermal water (STW)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: S-based compound (NaSH)
Number of subjects: 50
Study: 22288082

Group type: EXPERIMENTAL
Intervention: AccuO2
Number of subjects: 28

Group type: COMPARATOR
Intervention: Continuous-flow O2
Number of subjects: 28

Group type: COMPARATOR
Intervention: CR-50
Number of subjects: 28
Study: 19478215

Group type: EXPERIMENTAL
Intervention: GFR 50 to 59 mL/min/1.73 m2
Number of subjects: 5494

Group type: EXPERIMENTAL
Intervention: GFR <50 mL/min/1.73 m2
Number of subjects: 5494

Group type: COMPARATOR
Intervention: Optimal BP subjects without CKD
Number of subjects: 5494
Study: 17224851

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control
Number of subjects: 164
Study: 12093952

Group type: EXPERIMENTAL
Intervention: Forced use treatment (plaster cast on unimpaired arm for 1 month)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no cast)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Crossover control group (received casts after 6 months)
Number of subjects: 25
Study: 10624641

Group type: EXPERIMENTAL
Intervention: Sevoflurane 3%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sevoflurane 4%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sevoflurane 5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sevoflurane 6%
Number of subjects: 60
Study: 8745137

Group type: EXPERIMENTAL
Intervention: CAGE questionnaire
Number of subjects: 219

Group type: COMPARATOR
Intervention: Other diagnostic tests (Alcohol Clinical Index, MCV, GGT, GOT/GPT, GGT/AP)
Number of subjects: 219
Study: 1782716

Group type: EXPERIMENTAL
Intervention: Vaseline gauze nasal packing
Number of subjects: 50

Group type: COMPARATOR
Intervention: 30 Dexon mucosal suture
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 7284888

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (epidural)
Number of subjects: 0
Study: 29788977

Group type: EXPERIMENTAL
Intervention: B'more Healthy Communities for Kids (BHCK) intervention
Number of subjects: 385

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Age increase by 1 year
Number of subjects: 385
Study: 28034987

Group type: EXPERIMENTAL
Intervention: Manual therapy and specific neck exercises
Number of subjects: 50
Study: 23260098

Group type: EXPERIMENTAL
Intervention: Heated, humidified high-flow nasal cannulae (HHHFNC)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (NCPAP)
Number of subjects: 132
Study: 21613626

Group type: EXPERIMENTAL
Intervention: Endocanalicular, high-pressure, 5-mm balloon catheter, endoscopic DCR
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional endoscopic DCR
Number of subjects: 66
Study: 18436150

Group type: EXPERIMENTAL
Intervention: Brief psychosocial/behavioral intervention plus antidepressant
Number of subjects: 101

Group type: COMPARATOR
Intervention: Usual care including antidepressants
Number of subjects: 101
Study: 17138031

Group type: EXPERIMENTAL
Intervention: Systolic strain rate (SR) less than 2 s(‐1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Systolic strain rate (SR) greater than 2 s(‐1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Depressed systolic strain rate (SR)
Number of subjects: 15
Study: 15514496

Group type: EXPERIMENTAL
Intervention: Montelukast (ML) 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study: 10426846

Group type: EXPERIMENTAL
Intervention: Locally delivered urokinase
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 54
Study: 7552181

Group type: EXPERIMENTAL
Intervention: Metered dose inhaler
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Spacer
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Aerochamber
Number of subjects: 13
Study: 2249707

Group type: EXPERIMENTAL
Intervention: Two periods of resource room instruction per day
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Consultative services combined with in‐class instruction
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Consultative services to classroom teachers
Number of subjects: 67

Group type: COMPARATOR
Intervention: Resource room instruction (one period per day)
Number of subjects: 67
Study: 7416947

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without digoxin)
Number of subjects: 0
Study: 31216321

Group type: EXPERIMENTAL
Intervention: modulated electro-hyperthermia (mEHT) administered 2/weekly immediately before external beam radiation
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control (chemoradiotherapy without mEHT)
Number of subjects: 202
Study: 29675640

Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) and whey protein supplementation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 67
Study: 26876014

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 26449

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26449
Study: 24848812

Group type: EXPERIMENTAL
Intervention: 18-gauge nonfenestrated catheter
Number of subjects: 205

Group type: COMPARATOR
Intervention: 20-gauge fenestrated catheter
Number of subjects: 205

Group type: COMPARATOR
Intervention: 20-gauge fenestrated catheter (third cohort)
Number of subjects: 205
Study: 22169051

Group type: EXPERIMENTAL
Intervention: SC golimumab 100 mg every 4 weeks through week 20 (n = 33)
Number of subjects: 49

Group type: COMPARATOR
Intervention: IV golimumab 2 mg/kg at weeks 0 and 12 (n = 16)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: SC golimumab
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Patients with concomitant MTX use
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Patients without concomitant MTX use
Number of subjects: 49

Group type: COMPARATOR
Intervention: Comparison of CL/F with and without MTX
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Overall tolerability of golimumab
Number of subjects: 49
Study: 21132998

Group type: EXPERIMENTAL
Intervention: Avonex (Av)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rebif (Re)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Betaferon (Be)
Number of subjects: 90
Study: 18175518

Group type: EXPERIMENTAL
Intervention: Oral estradiol 2 mg daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Transdermal estradiol 0.05 mg daily
Number of subjects: 45
Study: 15765114

Group type: EXPERIMENTAL
Intervention: Autologous HSCT
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: Autologous HSCT with cyclophosphamide during mobilization
Number of subjects: 473
Study: 12410054

Group type: EXPERIMENTAL
Intervention: Chewing fruit-flavored chewing gum for 10 minutes
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Betel chewing
Number of subjects: 30
Study: 10218748

Group type: EXPERIMENTAL
Intervention: COER-verapamil (180 to 480 mg)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Nifedipine GITS (30 to 120 mg/d)
Number of subjects: 528
Study: 7502998

Group type: EXPERIMENTAL
Intervention: Pet ownership (dog owners)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: High social support
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Overall social support
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Pet ownership
Number of subjects: 424
Study: 31850987

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (gastric bypass, banding, or vertical banded gastroplasty)
Number of subjects: 2007

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (specific types not detailed)
Number of subjects: 2007

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2007
Study: 29733225

Group type: EXPERIMENTAL
Intervention: Right carotid sinus compression for 20 sec
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo technique of placing hands on the radial styloid processes
Number of subjects: 64
Study: 28083873

Group type: EXPERIMENTAL
Intervention: Problem-based learning (PBL) course
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional lecture-based courses
Number of subjects: 90
Study: 25060039

Group type: EXPERIMENTAL
Intervention: Sitting Tai Chi
Number of subjects: 59

Group type: COMPARATOR
Intervention: Mobilizing exercises (Control)
Number of subjects: 59
Study: 24093362

Group type: EXPERIMENTAL
Intervention: Higher health literacy
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: Higher health literacy among non-Hispanic White participants
Number of subjects: 581

Group type: EXPERIMENTAL
Intervention: Higher health literacy among Hispanic/other race participants
Number of subjects: 581
Study: 21831504

Group type: EXPERIMENTAL
Intervention: Simulation-based training course
Number of subjects: 54
Study: 20016176

Group type: EXPERIMENTAL
Intervention: AmF/SnF(2) toothpaste + AmF/SnF(2) mouthwash
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AmF/SnF(2) toothpaste + tap water rinse
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: AmF/SnF(2) toothpaste + no rinse (spit out only)
Number of subjects: 30
Study: 17097048

Group type: EXPERIMENTAL
Intervention: Video containing information based on the Self Regulatory Model of health beliefs
Number of subjects: 44

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 44
Study: 15251644

Group type: EXPERIMENTAL
Intervention: Intravenous insulin infusion therapy
Number of subjects: 0
Study: 11704175

Group type: EXPERIMENTAL
Intervention: Intensive therapy (mean 3.8 sessions with obstetrician and one with midwife)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Conventional therapy (mean 2.0 sessions)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 176
Study: 9310537

Group type: EXPERIMENTAL
Intervention: Continuous nasogastric gavage (CNG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intermittent bolus gavage (IBG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CNG
Number of subjects: 80

Group type: COMPARATOR
Intervention: IBG
Number of subjects: 80
Study: 7514705

Group type: EXPERIMENTAL
Intervention: Acetic acid (all four concentrations)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amyl acetate (all four concentrations)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Phenethyl alcohol (all four concentrations)
Number of subjects: 10
Study: 3311285

Group type: EXPERIMENTAL
Intervention: Transumbilical incision
Number of subjects: 115

Group type: COMPARATOR
Intervention: Circumumbilical incision
Number of subjects: 115
Study: 31999297

Group type: EXPERIMENTAL
Intervention: Cessation of treatment with good visual acuity (CTGVA) group
Number of subjects: 625

Group type: COMPARATOR
Intervention: Other group
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: CTGVA group
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: CTGVA group (as-needed treatment)
Number of subjects: 625
Study: 29476546

Group type: EXPERIMENTAL
Intervention: CAL-assisted MAL-PDT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional MAL-PDT
Number of subjects: 20
Study: 27852241

Group type: EXPERIMENTAL
Intervention: 25° back‐up position
Number of subjects: 781

Group type: COMPARATOR
Intervention: Standard supine sniffing position
Number of subjects: 781
Study: 23743817

Group type: EXPERIMENTAL
Intervention: Light-emitting diodes therapy (LEDT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham application
Number of subjects: 10
Study: 22539379

Group type: EXPERIMENTAL
Intervention: Hemocoagulase (2U daily for 2 days postoperatively)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no hemocoagulase)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hemocoagulase
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 19944893

Group type: EXPERIMENTAL
Intervention: Maxillomandibular advancement (MMA) surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Autotitrating positive airway pressure (APAP)
Number of subjects: 50
Study: 19708820

Group type: EXPERIMENTAL
Intervention: Antigen-specific therapies
Number of subjects: 0
Study: 15850125

Group type: EXPERIMENTAL
Intervention: Maximal effort single-leg vertical jumps on the dominant leg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Maximal effort single-leg vertical jumps on the non-dominant leg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Comparison of jump height between men and women
Number of subjects: 25

Group type: COMPARATOR
Intervention: Assessment of thigh length and peak vertical ground reaction force
Number of subjects: 25

Group type: COMPARATOR
Intervention: Analysis of minimum ankle and hip angles, and vertical ground reaction forces
Number of subjects: 25
Study: 12848782

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg once daily
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Formoterol 9 micro g twice daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10568080

Group type: EXPERIMENTAL
Intervention: Greater impairment in instrumental activities of daily living
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Cognitive disorder
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: High scores on the General Health Questionnaire
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Psychotic disorder
Number of subjects: 881
Study: 8739811

Group type: EXPERIMENTAL
Intervention: Tolcapone 100 mg t.i.d.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tolcapone 200 mg t.i.d.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tolcapone 400 mg t.i.d.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tolcapone 800 mg t.i.d.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Levodopa/benserazide 100/25 mg (given on days 2 and 7)
Number of subjects: 32
Study: 1831059

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) 300 mg five times daily
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 193
Study: 6642790

Group type: EXPERIMENTAL
Intervention: Cadralazine (CD) 15 mg 1 X daily, increased to 20 mg 1 X daily if poor response
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dihydralazine (HD) 25 mg 3 X daily, increased to 50 mg 2 X daily if poor response
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dihydralazine (HD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cadralazine (CD)
Number of subjects: 20
Study: 30430372

Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU caplets, administered weekly)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (administered weekly)
Number of subjects: 35
Study: 30241565

Group type: EXPERIMENTAL
Intervention: Low calorie high protein diet (HP) with protein as 22-30% total calorie intake for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low calorie standard protein diet (SP) with protein as 12-20% total calorie intake for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between HP and SP groups
Number of subjects: 0
Study: 26702120

Group type: EXPERIMENTAL
Intervention: FruEx (exercise, then fructose condition)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ExFru (exercise, then fructose condition)
Number of subjects: 8

Group type: COMPARATOR
Intervention: NoEx (fructose treatment alone with no exercise condition)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: FruEx
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ExFru
Number of subjects: 8

Group type: COMPARATOR
Intervention: NoEx
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 8
Study: 23798005

Group type: EXPERIMENTAL
Intervention: Reasons for Living (RFL)
Number of subjects: 1075
Study: 22574737

Group type: EXPERIMENTAL
Intervention: Sodium butyrate (80 mM) enema, twice daily for 3 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80
Study: 21117498

Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride immediate-release tablet formulations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental conditions for metformin hydrochloride release
Number of subjects: 0
Study: 17463382

Group type: EXPERIMENTAL
Intervention: Intervention group (fathers participated in the intervention)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Control group (fathers did not participate in the intervention)
Number of subjects: 277
Study: 15277137

Group type: EXPERIMENTAL
Intervention: Teaching workshop for residents (two-day workshop)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 16
Study: 11444420

Group type: EXPERIMENTAL
Intervention: Marketed calcium carbonate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Encapsulated calcium carbonate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Marketed calcium citrate
Number of subjects: 24

Group type: COMPARATOR
Intervention: No-load blank
Number of subjects: 24
Study: 9553833

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture at the non-sympathetic, placebo point
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture at the sympathetic point
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (no acupuncture)
Number of subjects: 38
Study: 7925171

Group type: EXPERIMENTAL
Intervention: Vigabatrin (gamma-vinyl GABA, VGB)
Number of subjects: 20
Study: 2454027

Group type: EXPERIMENTAL
Intervention: Piroxicam 40 mg daily for two days, then 20 mg once daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily for two days, then 375 mg twice daily
Number of subjects: 34
Study: 29489734

Group type: EXPERIMENTAL
Intervention: Anodal left temporal lobe stimulation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cephalic montage (anode over left temporal lobe, cathode over right prefrontal cortex)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Extracephalic montage (cathode on shoulder)
Number of subjects: 38
Study: 28697767

Group type: EXPERIMENTAL
Intervention: Rosuvastatin and Ezetimibe administered in the morning (8:00 am) for 6 weeks and then in the evening for the next 6 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Rosuvastatin and Ezetimibe administered in the evening (8:00 pm) for the first 6 weeks and then in the morning for the following 6 weeks
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Rosuvastatin and Ezetimibe (both administration times)
Number of subjects: 200
Study: 26525836

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (EC-MPS)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 92
Study: 23813584

Group type: EXPERIMENTAL
Intervention: Bilateral paraspinal mapping and testing of 6 muscles on the most symptomatic limb
Number of subjects: 73
Study: 21181600

Group type: EXPERIMENTAL
Intervention: Online version of the Weight Management Support Inventory
Number of subjects: 199

Group type: COMPARATOR
Intervention: Paper version of the Weight Management Support Inventory
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Posting messages on Internet forums several times per day
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Instrumental support items in the Weight Management Support Inventory
Number of subjects: 199
Study: 19762739

Group type: EXPERIMENTAL
Intervention: Sevoflurane (3 times 30 min at 2 vol% interspersed by 30 min of air)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane inhalation (<1 vol% end-tidal concentration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 0
Study: 17174222

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg/d
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: rosiglitazone 8 mg/d
Number of subjects: 598

Group type: COMPARATOR
Intervention: glibenclamide
Number of subjects: 598